Updated Monday through Friday
- Drug Firm Annual Registration Status
- Drug Firm Annual Registration Status Download File
- National Drug Code Directory
- NDC Unfinished Drugs Excluded Database File
- NDC Database Excluded Packages and Products
- Wholesale Distributor and Third-Party Logistics Providers Reporting
January 23, 2020
- Assessing User Fees Under the Biosimilar User Fee Amendments of 2017 Guidance for Industry
- In Vitro Drug Interaction Studies — Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industry
- Clinical Drug Interaction Studies — Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industry
- Comunicaciones de la FDA sobre la seguridad de los medicamentos en español: El ensayo clínico de seguridad demuestra un posible aumento del riesgo de cáncer con el medicamento para la pérdida de peso Belviq, Belviq XR (lorcaserina)
- FDA Drug Safety Podcast: Safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)
- FDA Drug Shortages
- Cefazolin Injection (Updated - Currently in Shortage)
- Cefoxitin for Injection, USP (Currently in Shortage)
- Levetiracetam Extended-Release Oral Tablets, USP (Updated - Currently in Shortage)
- Temozolomide (TEMODAR) Capsules (New - Discontinuation)
No hay comentarios:
Publicar un comentario